Your Incentive Program
CY2026 · 195 eligible members · $20 PMPM
Annual Maximum
$0195 members × $20 × 12 months
Quarterly Max
$11,700
50% Quality · 50% AWV/HCC
2024 Actual (Prior Year)
$0of $7,100 potential · $8.33 eff. PMPM
Priority Measures
CY2026 · Medicare Advantage · Quarterly targets
Controlling Blood Pressure
Glycemic Status in Diabetes
Kidney Health Evaluation
Medication Adherence (Combined)
Quick Wins
Patients closest to compliance — minimal effort to close
Medication Alerts
Overdue refills impacting adherence
Metformin 850mg · CVS Pharmacy
Losartan 50mg · CVS Pharmacy
Lisinopril 10mg · Rite Aid
Atorvastatin 40mg · CVS Pharmacy
Metformin 500mg · MedRite Pharmacy
Pillar 2 — AWV & Risk Adjustment
50% of PMPMHCC documentation · AWV completion · RAF accuracy
AWV Completion
Annual Wellness Visits
133 of 195 completed
Target: 85%
62 AWVs remaining
Target: 85%
HCC Recapture
Risk adjustment documentation
High Confidence (>85%)
20 members · 24 HCCs
Medium Confidence (67.5–85%)
26 members · 28 HCCs
Top HCC Targets
Utilization Overview
Performance vs. network benchmarks
| Measure | Performance | Network Benchmark | Opportunity / Comments |
|---|---|---|---|
| Utilization & Cost Trend (PMPM) | $812 | $745 | Higher than peers — review high-cost drivers |
| Readmission Rate (30-day) | 14.2% | >7% | Avoidable CHF/COPD admissions noted |
| ADK (Acute Admission per 1,000) | 102 | 88 | Elevated — care management referral opportunities |
| EDK (ED Visits per 1,000) | 312 | 260 | High non-emergent ED utilization |
| TRC Engagement (Post-Discharge) | 63% | 78% | Outreach gaps within 48 hours of discharge |
| Brand-to-Generic Conversion | 76% | 85% | Candidates: rosuvastatin, duloxetine, sitagliptin |
| Site-of-Service Optimization | 21% | 34% | Shift infusions & imaging to ambulatory centers |
2026 Medicare PCP Provider Incentive Program
224 total MA members · 195 Emblem + Aetna · Quarterly payouts · Richmond County
Rep
Kalilou Kane
NPI
1033284906
Practice
Nicolette E. Filitis, MD